CD4 and tuberculosis: Additionally, in patients with TB who present with advanced immunodeficiency (CD4 count < 200 cells/mm3), early initiation of ART (< 8 weeks after TB treatment initiation) increases survival, as demonstrated in several large clinical trials [9–12].